↓ Skip to main content

Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, February 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
60 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
Published in
Journal of Experimental & Clinical Cancer Research, February 2019
DOI 10.1186/s13046-019-1072-8
Pubmed ID
Authors

Jia Wei, Ling Ma, Yi-Hui Lai, Ruijie Zhang, Huameng Li, Chenglong Li, Jiayuh Lin

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 60 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 12 20%
Researcher 9 15%
Student > Ph. D. Student 5 8%
Student > Master 4 7%
Student > Doctoral Student 3 5%
Other 7 12%
Unknown 20 33%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 17 28%
Medicine and Dentistry 6 10%
Pharmacology, Toxicology and Pharmaceutical Science 4 7%
Computer Science 3 5%
Agricultural and Biological Sciences 2 3%
Other 6 10%
Unknown 22 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 February 2022.
All research outputs
#8,538,940
of 25,385,509 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#574
of 2,382 outputs
Outputs of similar age
#169,207
of 448,771 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#26
of 87 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,382 research outputs from this source. They receive a mean Attention Score of 4.8. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,771 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 87 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.